glp-1 for iih receptor agonists may improve outcomes in idiopathic intracranial hypertension NeuroOp Guru: Stopping GLP-1 therapy

Getting vaccinated remains the best way to prevent long Covid, and studies have found that taking the antiviral Paxlovid during an infection can also reduce the risk of developing it

With continuing developments in the field of GLP-1 RA therapy, it is important for physicians to understand the benefits and practical use of GLP-1 RAs, as well as the clinical evidence, in order to achieve positive patient outcomes

doi: 10.1007/s00125-015-3795-1 [DOI] [PMC free article] [PubMed] [Google Scholar] 27

Novo Nordisk provides patient assistance for those who qualify

Xiong, A

Adverse Dermatological Effects of GLP-1RAs The administration of GLP-1RAs can lead to various skin reactions that range from injection-site localized responses to serious immune system-triggered conditions such as systemic hypersensitivity reactions (refer to Table 1)